1. Carmichael SW, Winkler H. The adrenal chromaffin cell. Scientific Am 1986;August. 30–39.
2. Kohler C, Berkowitz BA, Spector S. Sex hormones and tyrosine hydroxylase activity in vascular and adrenal tissue. Endocrionlogy 1975;97:1316–1320.
3. Fernandez-Ruiz JJ, Esquifino AI, Steger RW, Amador AG, Bartke A. Presence of tyrosine-hydroxylase activity in anterior pituitary adenomas and ectopic anterior pituitaries in male rats. Brain Res 1987;421:65–68.
4. Barclay SR, Harding CF. Differential modulation of monoamine levels and turnover rates by estrogen and/or in hypothalmic and vocal control nuclei of male zebra finches. Brain Res 1990;523:251–262.
5. Beattie CW, Soyka LF. Influence of progestational steroids on hypothalamic tyrosine hydroxylase activity in vitro. Endocrinology 1973;93:1453–1455.
6. Kamberi IA, Kobayashi Y. Monoamine oxidase activity in the hypothalamus and various other brain areas and in some endocrine glands of the rat during the estrocus cycle. J Neurochem 1970;17:261–268.
7. Francis PT, Gladwell RT, Hollman RB. The effect of testosterone on the release of endogenous catecholamines from the hypothalamus of the cockerel in vitro. Psychoneuroendocrinology 1984;9:69–76.
8. Paul SM, Axelrod J, Saavedra JM, Skolnick P. Estrogen-induced efflux of endogenous catecholamines from the hypothalamus in vitro. Brain Res 1979;178:499–505.
9. Nixon RL, Janowsky DS, Davis JM. Effects of progesterone, β-estradiol and testosterone on the uptake and metabolism of
3H-norepinephrine,
3H-dopamine and
3H-serotonin in rat brain synaptosome. Res Commun Chem Pathol Pharmacol 1974;7:233–336.
10. Hua SY, Chen YZ. Membrane receptor-mediated electrophysological effects of glucocortiocoid on mammalian neurons. Endocrinology 1989;124:687–691.
11. Nabekura J, Oomure Y, Minami T, Mizuno Y, Fukuda A. Mechanism of the rapid effect of 17-β-estradiol on medial amygdala neurons. Science (Wash DC) 1986;233:226–228.
12. Miguel RD, Fernandez-Ruiz JJ, Heranandez ML, Ramos JA. Role of ovarian steroid on the catecholamine synthesis and release in female rat adrenal: In vivo and in vitro studies. Life Sci 1989;44:1979–1986.
13. Lopez MG, Abad F, Sancho C, Pascual RD, Borges R, Maroto R, Dixon Wand Garcia AG. Membrane-mediated effects of the steroid 17-α-estradiol on adrenal catecholamine release. J Pharmacol Exp Ther 1991;259(1):279–285.
14. Leret ML, Martinez Y, Antonio MT, Gonzalez MI. Influence of amygdala catecholamines on ovarian and adrenal medullary secretion. Life Sci 1992;51:353–358.
16. Anton AH, Sayre DF. A study of the factors affecting the aluminum oxidetrihydroxy indole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 1962;138:360–375.
17. Tallarida RJ, Murray RB. Manual of pharmacologic calculation with computer programs. 2nd Ed. New York: Springer-Verlag, 1987;132.
18. Hammer R, Glachetti A. Muscarinic receptor subtypes: M
1 and M
2 biochemical and functional characterization. Life Sci 1982;31:2992–2998.
19. Schramm M, Thomas G, Towart R, Franckowiak G. Novel dihydropyridines with positive inotropic action through activation of Ca
2+ channels. Nature 1982;303:535–537.
20. Wada Y, Satoh K, Taira N. Cardiovascular profile of Bay-K-8644. a presumed clacium channel aotivatior in the dog. Naunyn-Schmiedebergs Arch Pharmacol 1985;328:382–387.
21. Garcia AG, Sala F, Reig JA, Viniegra S, Frias J, Fonteriz R, Gandia L. Dihydropyridine Bay-K-8644 activates chromaffin cell calcium channels. Nature 1984;309:69–71.
22. Lim DY, Kim CD, Ahn KW. Influence of TMB-8 on secretion of catecholamines from the perfused rat adrenal glands. Arch Pharm Res 1992;15(2):115–125.
23. Manickan P, Joy KP. Changes in hypothalamic catecholamine levels in relation to season, ovariectomy and 17-β-estradiol replacement in the catfish, Clarias batrachus (L.). Gen Comp Endocrinol 1990;80(2):167–174.
24. Skidmore JR, Walpole AL, Woodburn J. Effect of some triphenylethylenes on oestradiol binding in vitro to macromolecules from uterus and anterior pituitary. J Endocrinol 1972;52:289–298.
25. Jordan VA, koerner S. Tamoxifen (ICI 46, 474) and the human carcinoma 8s oestrogen receptor. Eur J Cancer 1975;11:205–206.
26. Jordan VC, Prestwich G. Binding of [
3H] tamoxifen in rat uterine cytosols. A comparison of swinging bucket and vertical tube rotor sucrose density gradient analysis. Mol Cell Endocrinol 1977;8:179–188.
27. Collet AR, Story DF. Is catecholamine release from the rabbit adrenal gland subject to regulation through dopamine receptos or beta-adrenoceptors? Clin Exp Pharmacol Physiol 1982a;9:436.
29. Fernandez-Ruiz JJ, Bukhari AR, Martinez-Arrieta R, Tresquerres JAF, Ramos JA. Effects of estrogens and progesterone on the catecholaminergic activity of the adrenal medulla in female rats. Life Sci 1988;42(9):1019–1028.
30. MacEwen BS, Parson B. Gonadal steroid action on the brain: Neurochemistry and neuropharmacology. Annu Rev Pharmacol Toxicol 1982;22:555–598.
31. Hruska RE. Elevation of striatal dopamine receptors by estrogen: Dose and time studies. J Neurochem 1986;47(6):1908–1915.
32. Fernandez-Ruiz JJ, Amor Jo, Ramos JA. Time-dependent effects of estradiol and progesterone on the number of striatal dopaminergic D
2-receptors. Brain Res 1989;476:388–395.
33. Butcher RL, Collins WE, Fugo NW. Plasma concentration of LH, FSH, prolactin, progesterone and 17-beta estradiol throughout the 4-day estrosus cycle of the rat. Endocrinology 1974;94:1704–1708.
34. MacEwen BS. Trends Parmac 1985;6:22–26.
35. Calandra R, Naess O, Purvis K, Attramadal A, Djoseland O, Hansson V. Oestrogen receptors in the rat adrenal gland. J Steroid Biochem 1978;9(10):957–962.
36. MacEwen BS. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 1991;12:141–147.
37. Pfaff DW, Pfaffmann C. Olfactory and hormonal influences on the basal forebrain of the male rat. Brain Res 1969;15:137–156.
38. Kelly MJ, Moss RL, Dudley CA. The effects of microlectrophoretically applied estrogen, cortisol and acetylcholine on medial preoptic-septal unit activity throughout the estrous cycle of the female rat. Exp Brain Res 1977;30:53–64.
39. Sachs BD, Leipheimer RE. Rapid effect of testosterone on striated muscle activity in rats. Neuroendocrinology 1983;48:453–458.
40. Douglas WW. Secretomotor control of adrenal medullary secretion: Synaptic membrane and ionic events in stimulus-secretion coupling. Hanbook of Physiology. Sect. 7 vol. 6. In: Blashko H, Sayers G, Smith AD, eds. American Physiology Society, Washington D.C.: 1975;366–368.
43. Schneider AS, Cline HT, Rosenheck K, Sonenberg M. Stimulus-secretion coupling in isolated adrenal chromaffin cells: Calcium channel activation and possible role of cytoskeletal elements. J Neurochem 1981;37:567–575.
44. Holz RW, Senter RA, Frye RA. Relationship between CA
2+ uptake and catecholamine secretion in primary dissociated cultures of adrenal medulla. J Neurochem 1982;39:635–640.
45. Kao LS, Schneider AS. Calcium moblization and catecholamine secretion in adrenal chromaffin cells. J Biol Chem 1986;261:4881–4888.
46. Wakade AR, Wakade TD. Contribution of nicoitinic and muscarinic receptors in the secretion of catecholamines evoked by endogenous and exogenous acetylcholine. Neurscience 1983;10:973–978.
47. Kilpatrick DL, Slepetis R, Kirshner N. Ion channels and membrane potential in stimulus-secretion coupling in adrenal medulla cells. J Neurochem 1981;36:1245–1255.
48. Kilpatrick DL, Slepetis RJ, Corcoran JJ, Kirshner N. Calcium uptake and catecholamine secretion by cultured bovine adrenal medulla cells. J Neurochem 1982;38:427–435.
49. Knight D, Kesteven NT. Evoked transient intracellular free Ca
2+ changes and secretion in isolated bovine adrenal medullary cells. Proc R Soc Lond [Biol] 1983;218:177–199.
51. Wakade AR, Kahn R, Malhotra RK, Wakade CG, Wakade TD. McN-A-343. a specific agonist of M
1-muscarinic receptors, exerts ait niicotinic and antimuscarinic effects in the rat adrenal mudulla. Life Sci 1986;39:2073–2080.
52. Harish OE, Kao LS, Raffaniello R, Wakade AR, Schneider AS. Calcium dependence of muscarinic receptor-mediated catecholamine secretion from the perfused rat adrenal medulla. J Neurochem 1987;48:1730–1735.
53. Cheek RT, Burgoyne RE. Effect of activiation of muscarinic receptors on intracellular free calcium and secretion in bovine adrenal chromaffin cells. Biochim Biophys Acta 1985;846:167–173.
54. Kao LS, Schneider AS. Muscarinic receptors on bovine chromaffin cells mediate a rise in cytosolic calcium that is independent of extracellular calcium. J Biol Chem 1985;260:2019–2022.
55. Misbahuddin M, Isosaki M, Houchi H, Oka M. Muscarinic receptor-mediated increase in cytoplasmic free Ca
2+ in isolated bovine adrenal medullary cells. FEBS Lett 1985;190:25–28.
56. Lim DY, Hwang DH. Studies on secretion of catecholamines evoked by DMPP and McN-A-343 in the rat adrenal gland. Korean J Pharmacol 1991;27(1):53–67.
58. Wiseman H. Tamoxifen: New membrane-mediated mechnisms of action and therapeutic advances. Trend Pharmacol Sci 1994;15:83–89.
59. Abe M, Orita Y, Nakashima Y, Nakamura M. Hypertensive crisis induced by metoclopramide in a patient with pheochromocytoma. Angiology 1984;35(2):122–128.
60. Lim DY, Kim KH, Choi CH, Yoo HJ, Choi DJ, Lee EH. Studies on secretion of chatcholamines evoked by metoolopramide of the rat adrenal gland. J Korean Pharmacol 1989;25(1):31–42.